apt. Ivan Surya Pradipta, Ph.D
Research, Innovation and Partnerships Manager
 |
 |
PERSONAL
| Name | : | Ivan Surya Pradipta |
| Date & place of birth | : | June 20, 1983, & Yogyakarta |
| Affiliation | : | Department of Pharmacology & Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran |
| Address | : | Jl. Bandung-Sumedang Km. 21, Jatinangor, 45363 |
| Email address | : | ivanpradipta@unpad.ac.id |
| Position | : | Faculty member |
| Expertise | : | Clinical pharmacy & pharmacoepidemiology |
Education
| 2001 – 2006 | : | Bachelor of pharmacy, Universitas Padjadjaran- Indonesia |
| 2006 – 2007 | : | Profesional degree of pharmacy, Universitas Padjadjaran- Indonesia |
| 2007 – 2009 | : | Master of clinical pharmacy, Universitas Gadjah Mada- Indonesia |
| 2016 – 2020 | : | PhD in pharmacoepidemiology & Clinical Pharmacy, University of Groningen- the Netherlands
|
Organization
- International Society for Pharmacoepidemiology (ISPE), member 2013-2020
- European Society for Clinical Microbiology & Infectious Disease (ESCMID), member 2016-2020
- International Union Against Tuberculosis and Lung Disease, member 2018-2020
- Indonesian Pharmacist Association, member 2007-2020
- Indonesian researcher network for Tuberculosis/ JetSet TB Indonesia, Executive Board 2020-2021
Research & Research Grant (in the last 5 years)
| No. | Title | Year | Research Funder | IDR (thousands) |
| 1. | Behaviour study on self-medication antibiotic: An observational study in the Bandung’s adult population using the Health Belief Model approach | 2015 | Faculty of Pharmacy, Universitas Padjadjaran | 15,000 |
| 2. | Development of smart-phone application technology to improve treatment adherence for tuberculosis patients in Indonesia | 2020-2022 | Southeast Asia – Europe Joint Funding Scheme for Research and Innovation | 900,000 |
Community Service
| No. | Title | Year | Place | Funder/IDR |
| 1. | Member of epidemiology team for mitigating COVID-19 in West Java Province | 2020 | Bandung | The local government of West Java Province |
| 2. | Speaker on updated approach for pharmacist on tuberculosis management | 2020 | Bandung | Merck Sharp Dohme (MSD) |
Publications in the last 5 years (H-index: 10 (Scholar), 6 (Scopus))
International Journal
| No | Tittle | Journal | Year | Quartiles | |||
| Q1 | Q2 | Q3 | Q4 | ||||
| 1 | The clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review | The International Journal of Tuberculosis and Lung Disease 24 (8), 811-819 | 2020 | √ | |||
| 2 | Interventions to improve medication adherence in tuberculosis patients: a systematic review of randomized controlled studies | NPJ primary care respiratory medicine 30 (1), 1-10 | 2020 | √ | |||
| 3 | Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005–2015 | Antimicrobial Resistance & Infection Control 8 (1), 115 | 2019 | √ | |||
| 4 | Predictors for treatment outcomes among patients with drug-susceptible tuberculosis in the Netherlands: a retrospective cohort study | Clinical Microbiology and Infection 25 (6), 761. e1-761. e7 | 2019 | √ | |||
| 5 | A systematic review finds inconsistency in the measures used to estimate adherence and persistence to multiple cardiometabolic medications | Journal of Clinical Epidemiology 108, 44-53 | 2019 | √ | |||
| 6 | Association between DOTS program and the outcome of previous therapy in MDR-TB patients: a case study in Tasikmalaya district, West Java, Indonesia | Journal of Advanced Pharmacy Education & Research| Jan-Mar 9 (1) | 2019 | √ | |||
| 7 | Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis | Journal of Infection 77 (6), 469-478 | 2018 | √ | |||
| 8 | DNA methyltransferase 3A gene polymorphism contributes to daily life stress susceptibility | Psychology research and behavior management 10, 395 | 2017 | √ | |||
| 9 | Cost-Effectiveness Analysis Of Ceftazidime-Levofloxacin And Cefotaxime-Erythromycin As Empirical Antibiotic Combinations In Respiratory Infection-Induced Sepsis | Asian Journal of Pharmaceutical and Clinical Research | 2017 | √ | |||
| 10 | Off‐label paediatric drug use in an Indonesian community setting | Journal of Clinical Pharmacy and Therapeutics 40 (4), 409-412 | 2015 | √ | |||
| 11 | Three years of antibacterial consumption in Indonesian community health centers: The application of anatomical therapeutic chemical/defined daily doses and drug utilization 90 … | Journal of family & community medicine 22 (2), 101 | 2015 | √ | |||
| 12 | Induction of caspase cascade pathway by kaempferol-3-O-rhamnoside in LNCaP prostate cancer cell lines | Biomedical reports 3 (1), 115-117 | 2015 | √ | |||
National Accreditation Journal
| No | Tittle | Journal | Year | Sinta | ||
| S1-S2 | S3-S4 | S5-S5 | ||||
| 1 | Monitoring Penggunaan Antibiotik dengan Metode ATC/DDD dan DU90% di RSUD Abepura Jayapura, Indonesia | Indonesian Journal of Clinical Pharmacy 4 (3), 218-225 | 2015 | √ | ||
| 2 | Monitoring penggunaan antibiotik dengan metode ATC/DDD dan DU 90%: Studi observasional di seluruh puskesmas Kabupaten Gorontalo Utara | Jurnal Farmasi Klinik Indonesia 4 (4), 275-280 | 2015 | √ | ||
| 3 | Hubungan Persepsi terhadap Perilaku Swamedikasi Antibiotik: Studi Observasional melalui Pendekatan Teori Health Belief Model | Jurnal Farmasi Klinik Indonesia 4 (2), 82-83 | 2015 | √ | ||
SCIENTIFIC MEETINGS AS A SPEAKER IN THE LAST 5 YEARS
| No | Seminar/Symposium | Place | Year | Position | ||
| Plenary/Invited | Oral | Poster | ||||
| 1 | The third Post Graduate Seminar in Pharmaceutical
Sciences |
Jakarta, Indonesia | 2020 | √ | ||
| 2 | The 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management | Philadelphia, the United States | 2019 | √ | ||
| 3 | The 49th Union World Conference on Lung Health | The Hague, The Netherlands | 2018 | √ | ||
| 4 | The 49th Union World Conference on Lung Health | The Hague, The Netherlands | 2018 | √ | ||
| 5 | The 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management | Prague, Czech Republic | 2018 | √ | ||
REVIEWER/EDITOR
| a. Scientific Journal | ||
| No | Position and Journal | Year |
| 1 | Reviewer/ Open Forum Infectious Disease | 2020 |
| 2 | Reviewer/ Plos One | 2020 |
| 3 | Reviewer/ European Respiratory Review | 2020 |
| 4 | Reviewer/ Biomed Research International | 2020 |
| 5 | Reviewer/ The Lancet Infectious Disease | 2019 |
| 6 | Reviewer/ BMC Infectious Disease | 2019 |
| 7 | Reviewer/ BMC systematic review | 2019 |
| 8 | Reviewer/ Therapeutics and Clinical Risk Management | 2019 |
| 9 | Reviewer/ The American Journal of Tropical Medicine and Hygiene | 2019 |
| 10 | Reviewer/ International Journal of Integrated Health Sciences | 2019 |
| 11 | Reviewer/ Jurnal Farmasi Klinik Indonesia | 2018 |
| 12 | Reviewer/ Medical Journal Indonesia | 2018 |
| 13 | Reviewer/ The Journal of Infection in Developing Countries | 2018 |
| 14 | Reviewer/ Pharmacology and Clinical Pharmacy Research | 2016 |
Bandung, December 10, 2020
The updated scientific publications can be followed in the link below:
|
|
Other Members
Prof. Dr. apt. Anas Subarnas, M.Sc
Chairman of the Faculty Senate
Prof. Dr. apt. Ajeng Diantini, M.Si
Dean Faculty of Pharmacy
apt. Dika Pramita Destiani, M.Farm
Head of Clinical Pharmacy Laboratory
apt. Gofarana Wilar, M.Si., Ph.D
Head of Pharmacology Laboratory
Dr. apt. Sandra Megantara, M.Farm
Learning, Student Affairs and Alumni Manager
Intan Nurul Tanjung Arum, S.Sos
Resource, Planning and Information Manager
Prof. apt. Auliya A. Suwantika, Ph.D
Vice Dean for Resources and Organization
apt. Neily Zakiyah, M.Sc., Ph.D
Head of Pharmaceutical Service Innovations Study Center
